Skip to main content

Advertisement

Log in

Physicians’ perspectives on the diagnosis and management of periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome

  • Health Services Research
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

To assess the practice patterns of pediatric rheumatology and infectious diseases subspecialists in the diagnosis and treatment of periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome. An online survey assessing diagnostic and treatment approaches was sent to 424 members of the Childhood Arthritis and Rheumatology Research Alliance (CARRA) and 980 members of the Pediatric Infectious Disease Society (PIDS). 277 physicians (123 from CARRA and 154 from PIDS representing 21% of the total membership) completed the survey. To diagnose PFAPA, most respondents agreed that patients must have the following features of the diagnostic criteria: stereotypical fever episodes (95%), asymptomatic intervals between episodes (93%), and normal growth and development (81%). However, 71% of the respondents did not require age of onset <5 years, 33% did not require regular intervals between episodes, and 79% did not require the concomitant signs of aphthous stomatitis, adenitis, or pharyngitis during episodes as long as episodes were regular. Over half (58%) considered episode resolution with steroids to be diagnostic of PFAPA. Corticosteroids, antipyretics, tonsillectomy, and cimetidine were the most commonly prescribed treatments, while steroids and tonsillectomy were most effective. Subspecialists in pediatric rheumatology and infectious diseases showed limited adherence to the complete published criteria for diagnosing PFAPA suggesting heterogeneity in the characteristics of patients diagnosed with the disorder. These findings emphasize the need to develop consensus diagnostic and treatment guidelines in well-characterized patient populations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Gattorno M, Carosi R, Meini A, Cattalini M, Federici S, Zulian F et al (2009) Differentiating PFAPA syndrome from monogenic periodic fevers. Pediatrics 124:e721–e728

    Article  PubMed  Google Scholar 

  2. Krol P, Bohm M, Sula V, Dytrych P et al (2013) PFAPA syndrome: clinical characteristics and treatment outcomes in a large single-centre cohort. Clin Exp. Rheumatol 31:980–987

    PubMed  Google Scholar 

  3. Marshall GS, Edwards KM, Butler J, Lawton AR (1987) Syndrome of periodic fever, pharyngitis, and aphthous stomatitis. J Pediatr 110:43–46

    Article  CAS  PubMed  Google Scholar 

  4. Hofer M, Pillet P, Cochard MM, Berg S, Krol P, Kone-Paur I et al (2014) International periodic fever, aphthous stomatitis, pharyngitis, cervical adenitis syndrome cohort: description of distinct phenotypes in 301 patients. Rheumatology 53:1125–1129

    Article  PubMed  Google Scholar 

  5. Wurster VM, Carlucci JG, Feder HM, Edwards KM (2011) Long-term follow-up of children with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis syndrome. J Pediatr 159:958–964

    Article  PubMed  Google Scholar 

  6. Thomas KT, Feder HM, Lawton AR, Edwards KM (1999) Periodic fever syndrome in children. J Pediatr 135:15–21

    Article  CAS  PubMed  Google Scholar 

  7. Stojanov S, Lapidus S, Chitkara P, Feder H, Salazar JC, Fleisher TA et al (2011) Periodic fever, aphthous stomatitis, pharyngitis and adenitis (PFAPA) is a disorder of innate immunity and Th1 activation responsive to IL-1 blockade. Proc Natl Acad Sci 108:7148–7153

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Feder HM, Salazar JC. A clinical review of 105 patients with PFAPA (a periodic fever syndrome) (2010). Acta Paediatr 99: 178–184

  9. Brown KL, Wekell P, Osla V, Sundqvist M, Savman K, Fasth A, Karlsson A, Berg S (2010) Profile of blood cells and inflammatory mediators in periodic fever, aphthous stomatitis, pharyngitis and adenitis (PFAPA) syndrome. BMC Pediatr 10:65–75

    Article  PubMed  PubMed Central  Google Scholar 

  10. Licameli G, Lawton M, Kenna M, Dedeoglu F (2012) Long-term surgical outcomes of adenotonsillectomy for PFAPA syndrome. Arch Otolaryngol Head Neck Surg 138:902–906

    Article  PubMed  Google Scholar 

  11. Yazgan H, Gultekin E, Yazicilar O, Sagun OF, Uzun L (2012) Comparison of conventional and low dose steroid in the treatment of PFAPA syndrome: preliminary study. Int J Pediatr Otolaryngology 76:1588–1590

    Article  Google Scholar 

  12. Butbul AY, Tatour S, Gershone BR, Brik R (2016) Colchicine as a therapeutic option in periodic fever, aphthous stomatitis, pharyngitis, cervical adenitis (PFAPA) syndrome. Semin Arthritis Rheum 45:471–474

    Article  Google Scholar 

  13. Harris PA, Taylor R, Thielke R, Payne J, Payne, Gonzalez N, Conde JG (2009) Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42:377–381

    Article  PubMed  Google Scholar 

  14. Padeh S, Stoffman N, Berkun Y (2008) Periodic fever accompanied by aphthous stomatitis, pharyngitis and cervical adenitis syndrome (PFAPA syndrome) in adults. Isr Med Assoc J 10:358–360

  15. Tasher D, Somekh E, Dalal I (2006) PFAPA syndrome: new clinical aspects disclosed. Arch Dis Child 91:981–984

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Chandrakasan S, Chiwane S, Adams M, Fathalla BM (2014) Clinical and genetic profile of children with periodic fever syndromes from a single medical center in South East Michigan. J Clin Immunol 34:104–113

    Article  PubMed  Google Scholar 

  17. Federici S, Sormani M, Ozen S et al (2015) Evidence-based provisional clinical classification criteria for autoinflammatory periodic fevers. Ann Rheum Disease 74:799–805

    Article  Google Scholar 

Download references

Acknowledgements

We thank the members of CARRA and PIDS who participated in this survey and Sheffa Ariens (CARRA) and Christy Phillips (PIDS) for their help in distributing the survey. We are also grateful to Drs. Robert Sundel, Larry Zemel, Deborah Rothman, Lori Tucker, Debby McCurdy, Kelly Brown, and Annabelle de St. Maurice for their review of the survey. Dr. Tucker has received funding from Novartis to support research activities. No other conflicts of interest. CARRA is supported by Grants from National Institute of Arthritis and Musculoskeletal and Skin Diseases (RC2AR058934), Friends of CARRA, and the Arthritis Foundation, as well as by the Duke Clinical Research Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Arthritis and Musculoskeletal and Skin Diseases or the National Institutes of Health. Support for REDCap provided by Vanderbilt Institute for Clinical and Translational Research Grant support (UL1 TR000445 from NCATS/NIH). Kalpana Manthiram was supported by the Childhood Infection Research Program (1T32AI095202-01) and Conducting Child Health Care Research in Vulnerable Populations (1T32HD060554-05) training Grants from Vanderbilt University School of Medicine.

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to Sivia Lapidus.

Ethics declarations

Conflict of interest

Dr. Goldsmith is a member of the Novartis Advisory Speakers Board. Authors report no other conflicts of interest.

Additional information

Fatma Dedeoglu and Sivia Lapidus contributed equally as senior authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Manthiram, K., Li, S.C., Hausmann, J.S. et al. Physicians’ perspectives on the diagnosis and management of periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome. Rheumatol Int 37, 883–889 (2017). https://doi.org/10.1007/s00296-017-3688-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-017-3688-3

Keywords

Navigation